Compare Charles Schwab Corporation Common Stock (SCHW) vs 10X Genomics Inc (TXG) Price & Performance

Charles Schwab Corporation Common StockTrade

10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Charles Schwab Corporation Common Stock vs 10X Genomics Inc — how do they compare? Charles Schwab Corporation Common Stock trades at $100.17 (market cap $178.33B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 32.5× 10X Genomics Inc's market cap, and Charles Schwab Corporation Common Stock pays a 1.25% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.

	SCHW	TXG
Market Cap	$178.33B	$5.48B
Sector	Financials	Health
52-Week High	$107.21	$45.80
52-Week Low	$85.35	$11.34
Dividend Yield	1.25%	—
Enterprise Value	—	$5.02B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SCHW

Charles Schwab reports record Q2 earnings and raises stock price target to $118Andrew Wynn · 1 hour agoBullish Charles Schwab beats Q2 earnings and revenue estimates with record $7.07B revenue, despite rising expenses.Alex Lavoie · 2 hours agoBullish Wall Street braces for volatility as Big Tech earnings and AI updates dominate this week.Proactive Investors · 1 day agoNeutral View details →

TXG

New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

About Charles Schwab Corporation Common Stock

Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.